Synta To Present At Upcoming September Investor Conferences

Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will present at the following September investor conferences:

Rodman & Renshaw Annual Global Investment Conference in New YorkMonday, September 10 at 1:35 p.m. (ET)

ThinkEquity’s 9th Annual Growth Conference in New YorkWednesday, September 12 at 3:30 p.m. (ET)

UBS Global Life Sciences Conference in New YorkThursday, September 20, 2012 at 3:30 p.m. (ET)

Noble Financial Markets Life Sciences Exposition in Stamford, CTMonday, September 24, 2012 at 1:00 p.m. (ET)

Live audio webcasts and replays of these presentations will be available on the "Investors" section of the Company's website,

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit

Copyright Business Wire 2010

If you liked this article you might like

Fly Watch: Several Names That May Move Following ASCO Meeting

Synta Pharmaceuticals (SNTA) Stock Rises Today After Announcing Upcoming Presentations

Synta Pharmaceuticals (SNTA) Stock Hits 52-Week Low After Pricing Public Offering

5 Stocks Under $10 Set to Soar: Breakout Stocks

Interesting SNTA Call Options For March 20th